HALOZYME THERAPEUTICS, INC. (HALO) insider trading

By person

25 insiders · 385 transactions

84.8×

Helen I. Torley holds 84.8 times base salary in stock. $84.85M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Helen I. Torley last reported holding, valued at $110.51, the price Common Stock was last bought or sold at on the open market here, on 8 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Helen Torley

President and CEO

—

$103.17M (190) scheduled

−$103.17M

767,780

0.6765%

$84.85M

+568.1%

Randal J Kirk

10% owner

—

$61.57M (36)

−$61.57M

5,459,998

4.81%

$603.38M

−48.9%

Michael J. LaBarre

SVP, Chief Technical Officer

—

$25.02M (69) scheduled

−$25.02M

173,756

0.1531%

$19.20M

+10.5%

Matthew L. Posard

Director

—

$7.02M (16)

−$7.02M

53,609

0.0472%

$5.92M

−31.5%

Nicole LaBrosse

SVP, Chief Financial Officer

—

$3.91M (12) scheduled

−$3.91M

38,494

0.0339%

$4.25M

+664.8%

Kenneth J Kelley

Director

$748.70K (3)

$4.46M (11)

−$3.71M

179,833

0.1584%

$19.87M

−4.5%

Jeffrey William Henderson

Director

—

$3.32M (11)

−$3.32M

36,572

0.0322%

$4.04M

+37.5%

James M Daly

Director

—

$2.29M (4)

−$2.29M

20,503

0.0181%

$2.27M

+7.7%

Cortney Caudill

SVP, Chief Operating Officer

—

$2.23M (4) scheduled

−$2.23M

7,055

0.0062%

$779.65K

−8.1%

Connie Matsui

Director

—

$2.16M (3)

−$2.16M

183,035

0.1613%

$20.23M

−18.0%

Jean-Pierre Bizzari

Director

—

$1.44M (1)

−$1.44M

66,815

0.0589%

$7.38M

+81.5%

Bernadette Connaughton

Director

—

$1.28M (13) scheduled

−$1.28M

40,418

0.0356%

$4.47M

—

Mahesh Krishnan

Director

—

$547.80K (1) scheduled

−$547.80K

14,462

0.0127%

$1.60M

—

Dimitrios Chondros

SVP, Chief Medical Officer

—

$22.18K (1)

−$22.18K

38,584

0.0340%

$4.26M

+13.3%

Laurie Stelzer

SVP, Chief Financial Officer

—

116,167

0.1024%

$12.84M

+1,590%

Harry J Leonhardt

SVP, GC

—

66,373

0.0585%

$7.33M

+1,446%

Mark Howard Snyder

SVP, Chief Legal Officer

—

49,929

0.0440%

$5.52M

—

Athena Countouriotis

SVP and Chief Medical Officer

—

39,077

0.0344%

$4.32M

+95.6%

Akiko Moni Miyashita

Director

—

24,937

0.0220%

$2.76M

—

Barbara Gayle Duncan

Director

—

23,715

0.0209%

$2.62M

—

Masaru Matsuda

SVP, General Counsel

—

20,049

0.0177%

$2.22M

+346.6%

Elaine D Sun

SVP, Chief Financial Officer

—

14,018

0.0124%

$1.55M

—

Benjamin Hickey

SVP, Chief Commerical Officer

—

13,226

0.0117%

$1.46M

—

James Paul Lang

Director

—

4,685

0.0041%

$517.74K

—

David A Ramsay

EVP, President, Drug Delivery

—

4,592

0.0040%

$507.46K

—

HALOZYME THERAPEUTICS, INC.

What the insiders did Net selling

By person